Article Details

NeuroScientific Biopharmaceuticals (ASX:NSB) eye treatment passes safety study

Retrieved on: 2021-07-01 04:07:30

Tags for this article:

Click the tags to see associated articles and topics

NeuroScientific Biopharmaceuticals (ASX:NSB) eye treatment passes safety study. View article details on hiswai:

Excerpt

NeuroScientific Biopharmaceuticals' (NSB) eye treatment drug, EmtinB, passes safety and tolerability markers in a recent study; The ocular safety and ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up